GLP-1 / GIP / GCGR Tri-Agonist

Retatrutide

Retatrutide dark amber peptide research vial
99.5% Purity
HPLC/MS VerifiedWeight & MetabolicRank #02

Next-generation tri-agonist driving the new wave of metabolic studies.

Retatrutide is an investigational tri-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. A leading subject of emerging metabolic literature; 10mg is the prevailing analytical spec.

Spec

10mg · Lyophilized

Mass

10.11 mg

Purity

99.5%

Mechanism (in vitro)

Triple incretin pathway co-activation; elevated metabolic modulation potential vs. dual agonists.

Reconstitution

Reconstitute with 2 mL bacteriostatic water for a 5 mg/mL working concentration.

Storage

Store lyophilized at -20 °C. Reconstituted material stable at 2–8 °C for 28 days.

Price · Per Vial

$148.00

10mg

View Cart
Back to Catalog

Research & Operations

Frequently Asked Questions

Clinical-grade answers to the questions that matter most in advanced research procurement.